Weitz & Luxenberg attorneys Ellen Relkin and Robin Greenwald will discuss mass torts and pharmaceutical litigation at two upcoming conferences this October in Las Vegas…
Read MoreFirm News: Page 3
Category: Drugs & Devices
W&L Helping Patients Harmed by Smith & Nephew Knee Replacement Failure
Weitz & Luxenberg is accepting cases of people implanted with the first-generation Smith & Nephew Journey Bi-cruciate Stabilized (BCS) Knee replacement system (Journey I…
Category: Mesothelioma
W&L Wins $25 Million Verdict for California Couple Suffering Asbestos-Related Injuries
Weitz & Luxenberg attorneys Benno Ashrafi and Leonard Sandoval recently secured a $25 million dollar trial verdict for Houshang Sabetian, a former Iranian oil…
Category: Drugs & Devices
W&L Helping Patients Experiencing Blood Clots from Xeljanz Arthritis, Colitis Drug
Weitz & Luxenberg is accepting cases from arthritis and ulcerative colitis patients who have been taking Xeljanz (tofacitinib) or Xeljanz XR and have experienced deep…
Category: Mesothelioma, Our Firm
Perry Weitz Announced as Co-Chair of the Cutting-Edge Issues in Asbestos Litigation Conference
Weitz & Luxenberg co-founder Perry Weitz will co-chair the Cutting-Edge Issues in Asbestos Litigation Conference on March 11-12 at the Beverly Wilshire hotel in…
Category: Personal Injury
W&L Taking Cases of Brain Injury Resulting from Improperly Treated Vitamin B1 Deficiency Following Bariatric Weight Loss Surgery
Weitz & Luxenberg is now accepting cases of people who have suffered Wernicke’s encephalopathy (WE), also known as Wernicke encephalopathy, a neuropsychiatric disorder –…